GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bedrocan Cannabis Corp (FRA:8BC) » Definitions » EBITDA Margin %

Bedrocan Cannabis (FRA:8BC) EBITDA Margin % : -160.00% (As of Apr. 2015)


View and export this data going back to . Start your Free Trial

What is Bedrocan Cannabis EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bedrocan Cannabis's EBITDA for the three months ended in Apr. 2015 was €-0.53 Mil. Bedrocan Cannabis's Revenue for the three months ended in Apr. 2015 was €0.33 Mil. Therefore, Bedrocan Cannabis's EBITDA margin for the quarter that ended in Apr. 2015 was -160.00%.


Bedrocan Cannabis EBITDA Margin % Historical Data

The historical data trend for Bedrocan Cannabis's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bedrocan Cannabis EBITDA Margin % Chart

Bedrocan Cannabis Annual Data
Trend Jan13 Jan14 Jan15
EBITDA Margin %
- - -

Bedrocan Cannabis Quarterly Data
Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only - -11,900.00 -74.06 - -160.00

Competitive Comparison of Bedrocan Cannabis's EBITDA Margin %

For the Biotechnology subindustry, Bedrocan Cannabis's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bedrocan Cannabis's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bedrocan Cannabis's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Bedrocan Cannabis's EBITDA Margin % falls into.



Bedrocan Cannabis EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Bedrocan Cannabis's EBITDA Margin % for the fiscal year that ended in Jan. 2015 is calculated as

EBITDA Margin %=EBITDA (A: Jan. 2015 )/Revenue (A: Jan. 2015 )
=0/0
= %

Bedrocan Cannabis's EBITDA Margin % for the quarter that ended in Apr. 2015 is calculated as

EBITDA Margin %=EBITDA (Q: Apr. 2015 )/Revenue (Q: Apr. 2015 )
=-0.528/0.33
=-160.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bedrocan Cannabis  (FRA:8BC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Bedrocan Cannabis EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Bedrocan Cannabis's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bedrocan Cannabis (FRA:8BC) Business Description

Traded in Other Exchanges
N/A
Address
POCML 2 Inc is a capital pool company. The Company will not carry on any business other than the identification and evaluation of assets or businesses with a view to completing a proposed Qualifying Transaction.

Bedrocan Cannabis (FRA:8BC) Headlines

No Headlines